Avapritinib for treating moderate to severe indolent systemic mastocytosis [ID6578]

  • In development
  • GID-TA11772
  • Expected publication date: 

Documents

Documents created during the development process.

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators